Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II prolonged administration study of ME3738 in chronic hepatitis C
jRCT2080221188Phase 2
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of 22β-methoxyolean-12-ene-3β,24-diol in hepatitis C virus infection, sponsored by Meiji Seika Pharma Co., Ltd.
02
Drugs
22β-methoxyolean-12-ene-3β,24-diol
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on jRCT2080221188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221188.